新型代谢-预后整合揭示了TCF21介导的线粒体调节在子宫内膜癌

Ciren Guo1, Jianfeng Zheng1,2, Xuefen Lin1,2

  • 1Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

Molecular carcinogenesis
|September 22, 2025
PubMed
概括

这项研究确定了新陈代谢调节基因 (MRG) 来预测子宫内膜癌 (EC) 风险. 基因TCF21显示为瘤抑制剂的承诺,调节EC进展和线粒体代谢.